Literature DB >> 12372914

L-asparaginase-induced reversible posterior leukoencephalopathy syndrome in a child with acute lymphoblastic leukemia.

Bharti Rathi1, Rajeek K Azad, N Vasudha, Praveen Hissaria, Vijay Sawlani, Rakesh K Gupta.   

Abstract

Reversible posterior leukoencephalopathy syndrome (RPLS) is being increasingly described with various etiologies even in the absence of hypertension. We present an 11-year-old patient with acute lymphoblastic leukemia who presented with seizures while on treatment with L-asparaginase. MRI showed bilaterally symmetrical nonenhancing occipital lesions characteristic of RPLS. L-Asparaginase-induced RPLS is a rare cause of neurological symptoms in patients on induction chemotherapy. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12372914     DOI: 10.1159/000065395

Source DB:  PubMed          Journal:  Pediatr Neurosurg        ISSN: 1016-2291            Impact factor:   1.162


  5 in total

1.  Posterior reversible encephalopathy syndrome in an adult patient with acute lymphoblastic leukemia after remission induction chemotherapy.

Authors:  Shokichi Tsukamoto; Masahiro Takeuchi; Chika Kawajiri; Satomi Tanaka; Yuhei Nagao; Yasumasa Sugita; Atsuko Yamazaki; Takeharu Kawaguchi; Tomoya Muto; Shio Sakai; Yusuke Takeda; Chikako Ohwada; Emiko Sakaida; Naomi Shimizu; Koutaro Yokote; Tohru Iseki; Chiaki Nakaseko
Journal:  Int J Hematol       Date:  2011-12-09       Impact factor: 2.490

2.  Case files of the New York City poison control center: paradichlorobenzene-induced leukoencephalopathy.

Authors:  Stephanie H Hernandez; Sage W Wiener; Silas W Smith
Journal:  J Med Toxicol       Date:  2010-06

3.  Reversible posterior leukoencephalopathy syndrome following combinatorial cisplatin and pemetrexed therapy for lung cancer in a normotensive patient: A case report and literature review.

Authors:  Changqing Xie; Vovanti T Jones
Journal:  Oncol Lett       Date:  2015-12-24       Impact factor: 2.967

4.  Lysergic acid amide-induced posterior reversible encephalopathy syndrome with status epilepticus.

Authors:  Stephane Legriel; Fabrice Bruneel; Odile Spreux-Varoquaux; Aurelie Birenbaum; Marie Laure Chadenat; François Mignon; Nathalie Abbosh; Matthieu Henry-Lagarrigue; Laure Revault D'Allonnes; Pierre Guezennec; Gilles Troche; Jean Pierre Bedos
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

5.  Posterior Reversible Encephalopathy Syndrome in Pediatric Cancer: Clinical and Radiologic Findings.

Authors:  Saadiya Javed Khan; Arjumand Ali Arshad; Mohammad Bilal Fayyaz; Islah Ud Din Mirza
Journal:  J Glob Oncol       Date:  2017-12-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.